Scripps, IAVI to Establish $30 Million AIDS Vaccine Research Center

Xconomy San Diego — 

The Scripps Research Institute, the La Jolla, CA-based nonprofit research center, said today it will establish, along with the International AIDS Vaccine Initiative, the world’s first research center devoted to studying neutralizing antibodies against HIV. The International AIDS Vaccine Initiative will invest $30 million over five years in the center at Scripps, to house teams of scientists from multiple disciplines who will study how to generate broadly neutralizing antibodies against the HIV virus.  Scripps president Richard Lerner called it “the toughest challenge facing AIDS vaccine researchers today,” in a statement.